Access comprehensive insights on regulatory strategies and updates from Facet Life Sciences, guiding your path to compliance and approval.
When developing a new drug, early engagement with FDA through [...]
Preparing for a Pre-Biologics License Application (Pre-BLA) meeting with FDA [...]
For life sciences companies navigating the FDA regulatory landscape, Type [...]
Effective communication with FDA through various FDA meetings is essential [...]
When developing a new drug or biologic, timely and strategic [...]
A Type B meeting (also called a Milestone Meeting or [...]
Communication with FDA when developing innovative pharmaceuticals and biologics is [...]
By: Lisa VanLuvanee, Ph.D. Expanded access, also known as compassionate [...]
By Dr. Jason Mercer, Ph. D., RAC, Strategic Regulatory Innovator [...]
We are thrilled to have been a part of [...]
gET sOCIAL